| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Letermovir | 45.00 | High level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposure. ( 2014) | |
| Maribavir | 0.12 | Possible hypersensitivity, no resistance | Laboratory strain | Recombinant | Details | Antiviral activity of maribavir in combination with other drugs active against human cytomegalovirus. (Sep 2018) |
| Mutant | Resistances |
|---|---|
| V236A |
Letermovir:
|
| V236L |
Letermovir:
|